Conexeu is building a new class of aesthetic and wound care products from our innovative tissue research in regenerative medicine. Our patented CXU Scaffold Technology is a groundbreaking advancement in regenerative medicine. The company is leading the development and commercialization of cellular therapies for skin regeneration.

Conexeu’s first product Ten-Minute-Tissue™, is a liquid skin substitute which begins to transform and gel in the body, in about ~10 minutes. Inside the scaffold environment cells thrive and remodel into native tissue. Ideal for applications in wound care like burns, acute wounds and diabetic ulcers, with aesthetic indications for soft tissue fillers. 

The Ten-Minute-Tissue™ harnesses the regenerative properties of a patient’s own tissue cells for significantly faster wound closure and integration within the wound margins and fewer complications. It delivers enhanced patient outcomes with faster wound healing, minimizing complications, and reducing recovery times. 

Conexeu is leveraging its proven and differentiated capabilities to develop first-in-class cellular therapies for multiple indications in Aesthetics and Wound care markets, with indications for;
• Diabetic Ulcer Treatment
• Acute Care Wounds
• Chronic Wounds
• Derm-Filler and Soft Tissue Injectables market.


Biotechnology

Health Care

Life Sciences

Medical Devices

Conexeu Sciences Inc.

Org chart

Teams

Offices

Similar companies